COVID-19 - HealthQuill

Large study provides clues on immunity against Covid reinfection

A large study provides clues on how long immunity lasts against Covid reinfection and does vaccination help in reducing its severity

by HealthQuill
February 22, 2023
0 Comments

Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.

Drugs Health Medical Pharma

Novavax to supply 1.5m COVID-19 vaccine doses to US

Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.

by HealthQuill
February 14, 2023
0 Comments

A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged governments to increase surveillance.

Climate Drugs Pharma

H5N1 influenza’s spread to mammals needs ‘close monitoring’

A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged.

by HealthQuill
February 9, 2023
0 Comments

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA drugs.

Drugs Pharma

BioNTech to invest $43 million in new mRNA facility

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.

by HealthQuill
February 3, 2023
0 Comments

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near term’

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

by HealthQuill
February 1, 2023
0 Comments

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.

Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

by HealthQuill
February 1, 2023
0 Comments

The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.

Health Medical Pharma

U.S. to end Covid-19 curbs on May 11, migrant policy remains same

The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.

by HealthQuill
January 31, 2023
0 Comments

Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed evolution research.”

Drugs Medical Pharma

No ‘directed evolution research’ in COVID-19 vaccine: Pfizer

Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed.